LEXICON PHARMACEUTICALS INC (LXRX) Stock Income Statement
NASDAQ:LXRX - Nasdaq - US5288723027 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.21M | 31.08M | 1.20M | 100.00K | 300.00K | |||
| Cost Of Goods | 615.00K | 616.00K | 85.00K | 0.00 | 0.00 | |||
| Gross Profit | 30.60M | 30.46M | 1.12M | 100.00K | 300.00K | |||
| Operating Expenses | 208.06M | 227.58M | 172.87M | 100.90M | 87.40M | |||
| Research and Development | 85.41M | 84.48M | 58.89M | 52.80M | 55.00M | |||
| Selling, General, and Administrative Expenses | 122.65M | 143.10M | 113.98M | 48.10M | 32.30M | |||
| Operating Income | -177.46M | -197.12M | -171.75M | -100.80M | -87.10M | |||
| Interest Income/Expense | -12.47M | -15.58M | -13.10M | -2.80M | -800.00K | |||
| Other Income/Expense | 12.63M | 12.29M | 7.73M | 1.60M | 100.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Income Before Taxes | -177.30M | -200.40M | -177.12M | -101.90M | -87.80M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -177.30M | -200.40M | -177.12M | -101.90M | -87.80M | |||
| EBITDA | -176.90M | -196.58M | -171.20M | -100.40M | -86.80M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.51 | -0.63 | -0.80 | -0.62 | -0.60 | |||
| Non GAAP EPS | -0.51 | -0.64 | -0.80 | -0.61 | -0.61 | |||
| Statistics | ||||||||
| Gross Profit Margin | 98.03% | 98.02% | 92.94% | 100.00% | 100.00% | |||
| Profit Margin | -568.04% | -644.78% | -14710.88% | -101900.00% | -29266.67% | |||
| Operating Profit Margin | -568.55% | -634.20% | -14264.95% | -100800.00% | -29033.33% | |||
All data in USD